Melissa B, Epperly Insider Trading $ZNTL Zentalis Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Melissa B, Epperly.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Melissa B, Epperly. Melissa B, Epperly is Chief Financial Officer in Zentalis Pharmaceuticals, Inc. ($ZNTL).
Melissa B, Epperly in Zentalis Pharmaceuticals, Inc.
Trading Symbol: ZNTLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Melissa B, Epperly: Chief Financial Officer
Holdings: 265,973 shares
Latest Transaction: May 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Melissa B, Epperly in Zentalis Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 60.14 | 1,122 | 67,480 | 263,240 | 264.4 K to 263.2 K (-0.42 %) |
May 05 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 59.83 | 950 | 56,839 | 264,362 | 265.3 K to 264.4 K (-0.36 %) |
May 05 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 58.04 | 661 | 38,368 | 265,312 | 266 K to 265.3 K (-0.25 %) |
May 05 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 56.99 | 350 | 19,948 | 265,973 | 266.3 K to 266 K (-0.13 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 45.06 | 83 | 3,740 | 266,323 | 266.4 K to 266.3 K (-0.03 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 44.21 | 149 | 6,588 | 266,406 | 266.6 K to 266.4 K (-0.06 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 43.37 | 13,792 | 598,100 | 266,555 | 280.3 K to 266.6 K (-4.92 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 43.43 | 3,083 | 133,896 | 280,347 | 283.4 K to 280.3 K (-1.09 %) |
Feb 16 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Option Exercise | A | 38.76 | 45,000 | 1,744,200 | 45,000 | |
Feb 16 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 286,513 | 271.5 K to 286.5 K (+5.52 %) |
Jan 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 53.20 | 100 | 5,320 | 274,596 | 274.7 K to 274.6 K (-0.04 %) |
Jan 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 52.73 | 1,583 | 83,477 | 274,696 | 276.3 K to 274.7 K (-0.57 %) |
Jan 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 51.58 | 600 | 30,949 | 276,279 | 276.9 K to 276.3 K (-0.22 %) |
Jan 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.36 | 800 | 40,287 | 276,879 | 277.7 K to 276.9 K (-0.29 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 54.39 | 391 | 21,265 | 277,679 | 278.1 K to 277.7 K (-0.14 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 54.39 | 391 | 21,265 | 277,679 | 278.1 K to 277.7 K (-0.14 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 53.71 | 4,983 | 267,642 | 278,070 | 283.1 K to 278.1 K (-1.76 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 53.71 | 4,983 | 267,642 | 278,070 | 283.1 K to 278.1 K (-1.76 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 52.53 | 971 | 51,006 | 283,053 | 284 K to 283.1 K (-0.34 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 52.53 | 971 | 51,006 | 283,053 | 284 K to 283.1 K (-0.34 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.84 | 119 | 6,050 | 284,024 | 284.1 K to 284 K (-0.04 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.84 | 119 | 6,050 | 284,024 | 284.1 K to 284 K (-0.04 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 51.17 | 3,877 | 198,397 | 284,143 | 288 K to 284.1 K (-1.35 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 51.17 | 3,877 | 198,397 | 284,143 | 288 K to 284.1 K (-1.35 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.76 | 3,343 | 169,700 | 288,020 | 291.4 K to 288 K (-1.15 %) |
Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.76 | 3,343 | 169,700 | 288,020 | 291.4 K to 288 K (-1.15 %) |
Nov 25 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 47.26 | 300 | 14,177 | 294,446 | 294.7 K to 294.4 K (-0.10 %) |
Nov 25 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 46.51 | 2,783 | 129,436 | 294,746 | 297.5 K to 294.7 K (-0.94 %) |
Nov 25 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Buy | P | 18.00 | 20,000 | 360,000 | 297,529 | 277.5 K to 297.5 K (+7.21 %) |
Apr 09 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Grant | A | 0.00 | 147,394 | 0 | 277,529 | 130.1 K to 277.5 K (+113.26 %) |
Page: 1